Retatrutide

Retatrutide

Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G). Among its predecessors, Semaglutide (Ozempic, Rybelsus, Wegovy) and Tirzepatide (Mounjaro), Retartrutide is also a GLP-1/GIP and Glucagon/GLP-1 dual receptor co-agonist.  What does this mean?? It’s more potent than either Semaglutide or Tirzepatide with the addition of a pronounced appetite suppressing component feeling It’s the best of them all….

What does this mean in the real world?? Retatrutide is administered subcutaneously, with a half-life of 6 days, and therefore can be injected 1 x weekly. After 48 weeks, Retatrutide achieved 24.2% weight loss in obese or overweight patients and produced 17% weight loss in diabetic patients, making it arguably the most powerful 3G in the pipeline today. In addition, Retatrutide also achieved up to 86% reduction in liver fat in patients with NASH (non-alcoholic steatohepatitis). Quite simply, being overweight is now a choice – just 1 shot a week to make all the fat just melt away…

EACH VIAL CONTAINS:
Retatrutide BP 5mg
Peptides ship in a lyophilized (freeze-dried powder) form for maximum stability.
BAC water not included.
Ships with an express courier such as FedEx, DHL, or UPS.
Pay with Bitcoin and get a further 10% discount!
Buy 2 boxes, Get 1 box free!
Login to purchase

Before Placing Your Order:

Please read our FAQ to understand more about the ordering process.
VIEW FAQ

This product is a box of 10 vials.

Sample Dosing Schedule:

Serious Warning: Please dose this product responsibly. If you're new to the product, or haven't taken it in some time, you need to start small. Skipping to a high dose too soon will cause incredibly unpleasant & long-lasting side effects. Most users will not need to progress through to the highest dosage level to achieve substantial results.
Week 1 through 4 2.5mg per week Initial onboarding dose
Week 5 through 8 5mg per week Dose Escalation (if needed)
Week 9 through 12 7.5mg per week Dose Escalation (if needed)
Week 13 through 16 10mg per week Dose Escalation (if needed)
Week 17 through 20 12.5mg per week Dose Escalation (if needed)
Week 21+ 15mg per week Maximum indicated dose

What Is Retatrutide ?

Retatrutide is a version of GLP-1, a naturally occurring peptide known to lower blood sugar levels and boost insulin release. Studies show that Retatrutide (a GLP-1 analog) may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer's disease. Retatrutide has been shown to greatly reduce appetite by slowing stomach emptying and decreasing gut movement. Retatrutide has been changed to last longer in the body and have better drug properties.

retatrutide

Sequence: YA1QGTFTSDYSIL2LDKK4AQA1AFIEYLLEGGPSSGAPPPS3
Molecular Formula: C223H343F3N46O70
Molecular Weight: 4731.33 g/mol
PubChem CID: 171390338
CAS Number: 2381089-83-2
Synonyms: Retatrutide, LY-3437943, NOP2Y096GV, Triple agonist: GIP / GLP‑1 / glucagon receptor agonist

Curious about Retatrutide?

Join our Facebook group to engage directly with thousands of others who use this product, and follow our Facebook/IG pages for hot updates and product announcements!

IASP Facebook Group
IASP Facebook Page
IASP Instagram